ERBB2 and breast carcinoma: Another study demonstrated that BCL9 methylation status and its expression pattern are definitely related to ERBB2 and HER2 function in breast cancers ERBB2 and HER2 are both biomarkers of molecular subtypes of breast cancer; this functional link could consider BCL9 as a potential biomarker at the methylation level.